EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Universal Ibogaine's enterprise value is $8.39 Mil.
Universal Ibogaine's Revenue for the trailing twelve months (TTM) ended in Jan. 2025 was $1.37 Mil. Therefore, Universal Ibogaine's EV-to-Revenue for today is 6.11.
The historical rank and industry rank for Universal Ibogaine's EV-to-Revenue or its related term are showing as below:
IBOGF'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.96 Med: 5.6 Max: 252.83
Current: 6.11
During the past 8 years, the highest EV-to-Revenue of Universal Ibogaine was 252.83. The lowest was 1.96. And the median was 5.60.
IBOGF's EV-to-Revenue is ranked better than 54.66% of 997
companies
in the Biotechnology industry
Industry Median: 7.47
vs IBOGF: 6.11
The historical data trend for Universal Ibogaine's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Universal Ibogaine's EV-to-Revenue
For the Biotechnology subindustry, Universal Ibogaine's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Universal Ibogaine's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Universal Ibogaine's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Universal Ibogaine's EV-to-Revenue falls into.
Universal Ibogaine's current Enterprise Value is $8.39 Mil.
Universal Ibogaine's Revenue for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.37 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Universal Ibogaine's share price for today is $0.0218.
Universal Ibogaine's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Universal Ibogaine EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Universal Ibogaine's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IBOGF has been successfully added to your 